Table 4.

Female Sexual Function Index Intergroup Score Comparison of Women with Endometriosis-Associated Pain Symptoms at Baseline and at 3 and 6 Months of 24/4 Regimen 17β-Estradiol (1.5 mg) and Nomegestrol Acetate (2.5 mg) Combined Oral Contraceptive (Study Group) and of Women Using On-Demand Nonsteroidal Anti-Inflammatory Drugs (Control Group)

FSFI score	Baseline	3rd month follow-up	6th month follow-up
Study group	18.3 ± 1.5	27.5 ± 1.6	30.2 ± 1.8
	n = 99	n = 89	n = 77
Control group	18.7 ± 1.7	20.8 ± 1.4	22.9 ± 1.8
	n = 63	n = 57	n = 39
p	0.11	0.001	0.001
	95% CI: −0.90 to 0.11	95% CI: 6.18 to 7.21	95% CI: 6.59 to 8.1

Values are mean ± SD.

CI, confidence interval.